Aspirin Reduces COVID-19 Mortality: Investigator's Insights


Dr Jonathan Chow reviews study findings that patients with COVID-19 taking low-dose aspirin had reduced risk for use of ICU, mechanical ventilation, and of death.

Principal investigator Jonathan Chow, MD, assistant professor of anesthesiology at the University of Maryland School of Medicine, highlights study results and discusses possible mechanisms.

For details of Dr Chow's study, see: Low-dose Aspirin Reduces Risk of COVID-19 Mortality in Hospitalized Patients.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Related Content
© 2023 MJH Life Sciences

All rights reserved.